Identification of an Xiap-like pseudogene on mouse chromosome 7.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 2778954)

Published in PLoS One on November 30, 2009

Authors

Aneta Kotevski1, Wendy D Cook, David L Vaux, Bernard A Callus

Author Affiliations

1: Department of Biochemistry, La Trobe University, Bundoora, Victoria, Australia.

Articles by these authors

IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell (2007) 7.74

Error bars in experimental biology. J Cell Biol (2007) 5.81

Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature (2002) 3.15

HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem (2001) 2.33

Error message. Nature (2004) 2.27

TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J Cell Biol (2008) 2.11

Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene (2003) 2.03

cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner. Blood (2014) 1.97

Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance. Proc Natl Acad Sci U S A (2005) 1.91

Structures of the cIAP2 RING domain reveal conformational changes associated with ubiquitin-conjugating enzyme (E2) recruitment. J Biol Chem (2008) 1.87

TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis. J Biol Chem (2009) 1.68

Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J (2006) 1.67

IAPs limit activation of RIP kinases by TNF receptor 1 during development. EMBO J (2012) 1.61

A novel Apaf-1-independent putative caspase-2 activation complex. J Cell Biol (2002) 1.58

Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J Cell Biol (2004) 1.57

Apoptosis in the development and treatment of cancer. Carcinogenesis (2004) 1.53

The anti-apoptotic activity of XIAP is retained upon mutation of both the caspase 3- and caspase 9-interacting sites. J Cell Biol (2002) 1.41

In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8. J Biol Chem (2011) 1.40

Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase, but depends in part on Puma. Blood (2006) 1.31

Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization. J Biol Chem (2011) 1.25

Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response. Blood (2011) 1.22

The mitochondrial death squad: hardened killers or innocent bystanders? Curr Opin Cell Biol (2005) 1.22

Inhibition of Bak activation by VDAC2 is dependent on the Bak transmembrane anchor. J Biol Chem (2010) 1.22

Apoptosis. A cinderella caspase takes center stage. Science (2002) 1.21

Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9. J Cell Biol (2004) 1.18

Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding. J Biol Chem (2010) 1.09

Triggering of apoptosis by Puma is determined by the threshold set by prosurvival Bcl-2 family proteins. J Mol Biol (2008) 1.06

Asymmetric recruitment of cIAPs by TRAF2. J Mol Biol (2010) 1.04

Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors. Free Radic Biol Med (2010) 1.02

Multiple genetic loci modify susceptibility to plasmacytoma-related morbidity in E(mu)-v-abl transgenic mice. Proc Natl Acad Sci U S A (2002) 0.93

Distinct requirements for the Sprouty domain for functional activity of Spred proteins. Biochem J (2005) 0.92

Unlike Diablo/smac, Grim promotes global ubiquitination and specific degradation of X chromosome-linked inhibitor of apoptosis (XIAP) and neither cause apoptosis. J Biol Chem (2003) 0.91

Human Bcl-2 cannot directly inhibit the Caenorhabditis elegans Apaf-1 homologue CED-4, but can interact with EGL-1. J Cell Sci (2006) 0.90

Bioenergetic differences selectively sensitize tumorigenic liver progenitor cells to a new gold(I) compound. Carcinogenesis (2008) 0.85

CARP2 deficiency does not alter induction of NF-kappaB by TNFalpha. Curr Biol (2009) 0.77

Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics. Cancer Cell (2016) 0.77

In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-κB and activation of caspase-8. J Biol Chem (2016) 0.76

Correction: TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1. Elife (2017) 0.75

Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding. J Biol Chem (2017) 0.75